Ligand Pharmaceuticals
LGND | NASDAQ
$293.04
+$2.97 (+1.02%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 174.93M | 72.31M | 22.95M | 45.01M | 19.52M | 47.62M |
Short-Term Investments | 558.59M | 183.86M | 147.36M | 166.86M | 321.59M | 363.57M |
Long-Term Investments | 183.58M | 10.91M | 111.61M | 3M | n/a | n/a |
Other Long-Term Assets | 1.79M | 202.53M | 9.92M | 1.74M | 272.03M | 4.27M |
Receivables | 61.05M | 42.45M | 39.31M | 35.04M | 91.65M | 59.06M |
Inventory | 9.13M | 14.11M | 23.97M | 13.29M | 27.33M | 26.49M |
Other Current Assets | 28.58M | 16.9M | 2.66M | 2.27M | 4.67M | 3.82M |
Total Current Assets | 832.27M | 331.56M | 237.43M | 263.6M | 464.75M | 500.56M |
Property-Plant & Equipment | 10.79M | 24.81M | 25.06M | 27.49M | 32.6M | 37.17M |
Goodwill & Intangibles | 523.86M | 371.9M | 402.98M | 458.31M | 492.47M | 795.97M |
Total Long-Term Assets | 728.37M | 610.22M | 549.79M | 499.07M | 832.84M | 861.73M |
Total Assets | 1.56B | 941.77M | 787.22M | 762.67M | 1.3B | 1.36B |
Account Payables | 3.24M | 5.23M | 2.43M | 5.31M | 8.4M | 3.78M |
Deferred Revenue | 621K | 1.9M | 1.84M | 976K | 654K | 29.44M |
Short-Term Debt | n/a | n/a | n/a | 76.7M | n/a | n/a |
Other Current Liabilities | 6.81M | -3.2M | 4.94M | 6.26M | 22.57M | 49.38M |
Total Current Liabilities | 37.45M | 37.11M | 16.78M | 98.81M | 41.67M | 100.11M |
Long-Term Debt | 446.19M | n/a | n/a | n/a | 320.72M | 442.29M |
Other Long-Term Liabilities | 2.97M | 35.88M | 17M | 25.38M | 80.94M | 40.12M |
Total Long-Term Liabilities | 505.98M | 74.22M | 69.52M | 66.37M | 434.77M | 552.65M |
Total Liabilities | 543.43M | 111.34M | 86.3M | 165.18M | 476.43M | 652.76M |
Total Debt | 451.49M | 7.11M | 6.17M | 87.75M | 324.39M | 456.41M |
Book Value | 1.02B | 830.44M | 700.91M | 597.49M | 821.16M | 709.53M |
Book Value Per Share | 50.12 | 45.40 | 39.47 | 35.42 | 47.61 | 43.84 |
Common Stock | 20K | 20K | 18K | 17K | 17K | 16K |
Retained Earnings | 608.09M | 498.98M | 503.02M | 450.86M | 449.09M | 391.95M |
Comprehensive Income | 8.46M | -5.94M | -817K | -984K | -917K | -801K |
Shareholders Equity | 1.02B | 830.44M | 700.91M | 597.49M | 821.16M | 709.53M |
Total Investments | 742.18M | 194.77M | 258.97M | 169.86M | 321.59M | 363.57M |
Add to Watchlist
Select watchlists to add or remove LGND